People · Operator
Named in public records as an officer, director or promoter · active 2011–2019 · Biotechnology, Other, Pharma, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Gb Sciences Inc | — | Biotechnology | Series A | $24.8M | $8.7M | 2014 |
| OWP Ventures, Inc. | — | Other | Seed | $1.8M | $32.6M | 2019 |
| One World Pharma, Inc. | — | Pharma | Seed | $1.0M | $38.9M | 2019 |
| Phototron, Inc. | — | Other Technology | Pre-Seed | $503K | $21.3M | 2011 |
Craig Ellins at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Craig Ellins on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Bruce Raben | 2 | 3 |
| Brian Moore | 1 | 9 |
| Leslie Bocskor | 1 | 3 |
| John Poss | 1 | 2 |
| Todd Denkin | 1 | 2 |
| Steven Weldon | 1 | 2 |
| Dr. Kenneth Perego | 1 | 1 |
| Kenneth Perego | 1 | 1 |
| BRIAN SAGHEB | 1 | 1 |
| Andrea Small-Howard | 1 | 1 |
| Shane Terry | 1 | 1 |
| Zach Swarts | 1 | 1 |
| Krin Ellery Kuethe | 1 | 1 |
| Ksenia Griswold | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.